Urine of COVID-19 patients could predict who will develop severe disease

Written By : Hina Zahid

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-05-03 00:26 GMT | Update On 2021-05-03 00:26 GMT

Rockville, Md. -Urine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who were not infected with the coronavirus. In addition, levels of these inflammatory markers were higher in patients with comorbidities such as high blood pressure and diabetes, according to researchers from Wayne State University in Detroit. The findings will be presented virtually at the American Physiological Society's (APS) annual meeting at Experimental Biology 2021.

Currently, the most accurate test for the new coronavirus, SARS-CoV-2, is RT-PCR. However, it can take a day or more on most RT-PCR platforms to obtain results, and the technology may be too expensive for some hospitals and clinics.

The identification of genetic material of the virus by RT-PCR is the gold standard test, but its sensitivity is not satisfactory. The diagnosis of COVID-19 should be based on clinical data, epidemiological history, tests for etiological diagnosis, and tests to support the diagnosis of the disease and/or its complications. New diagnostic methods with higher sensitivity and specificity, as well as faster results, are necessary.

Researchers said they undertook this study in hopes of determining whether biomarkers of COVID-19 could predict which individuals will develop "overly exuberant immune responses," also called a cytokine storm. They chose to screen the urine of COVID-19 patients because of its non-invasive nature that doesn't require the use of needles or blood samples.

Scientists said they hope the results of this study will translate to a regular screening process for COVID-19 patients to predict who is more likely to develop severe disease and to aid in a successful treatment strategy.

Article Source : Experimental Biology 2021

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Hina Zahid

Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Worse outcomes with aspirin in high-risk chronic coronary syndrome patients who require long-term anticoagulation: ESC Study

2025-09-09 06:15 GMT

Urine of COVID-19 patients could predict who will develop severe disease

Similar News

Tooth Loss Significantly Increases Stroke Risk in Adults, suggests study

Myo-Inositol Does Not Reduce Pregnancy Risks in PCOS: JAMA

Adolescent Dysmenorrhoea Raises Risk of Chronic Pain in Adulthood, suggests study

Air Pollution Linked to Accelerated Kidney Function Decline, Reveals Large-Scale Study

Worse outcomes with aspirin in high-risk chronic coronary syndrome patients who require long-term anticoagulation: ESC Study

Monoclonal Antibodies Drive Pathogenesis in Heparin-Induced Thrombocytopenia: NEJM

FFR-Guided Complete Revascularization Beneficial in NSTEMI With Multivessel Disease: JAMA

Low BMI Raises Risk of TB in IGRA-Positive Contacts, suggests research